Wednesday, January 18, 2017

Scaling-up HCV treatment to achieve WHO targets by 2030

Accepted Articles

Editorial
Scaling-up HCV treatment to achieve WHO targets by 2030
Graham Cooke

Accepted manuscript online: 10 January 2017
DOI: 10.1111/tmi.12837

Download Article

Abstract
WHO recently launched a new strategy for tackling viral hepatitis with ambitious goals for reducing both deaths and new infections by 2030 [1]. Antiviral therapy is one only part of a multi-faceted strategy needed to tackle viral hepatitis, but for hepatitis C (HCV), the absence of an effective vaccine means that achieving these targets is going to require substantial scale-up of HCV treatment. Reaching the target of treating 80% of those in need by 2030 will require reaching at least 70 million people [2].....

Continue reading....

Article Of Interest
HCV Universal Treatment Access /Global Elimination - Targeted direct-acting antiviral treatment for chronic hepatitis C: A financial reality or an obstacle to elimination? - Editorial

No comments:

Post a Comment